| HMS LINCS ID:
|
50036
|
| Name:
|
NCI-H2023
|
| Alternative Names:
|
H2023
|
| LINCS ID:
|
LCL-1599
|
| Alternative ID:
|
CLO_0008039
|
| Parent Cell Line:
|
|
| Reference Source:
|
ATCC CRL-5912
|
| Organism:
|
Homo sapiens
|
| Organ:
|
lung
|
| Tissue:
|
|
| Cell Type:
|
|
| Details of Cell Type:
|
|
| Donor Sex:
|
male
|
| Donor Age:
|
|
| Donor Ethnicity:
|
|
| Donor Health Status:
|
|
| Disease:
|
DOID:3908, non-small cell lung carcinoma
|
| Details of Disease:
|
NSCLC carcinoma
|
| Production Details:
|
|
| Genetic Modification(s):
|
none
|
| Known Mutations:
|
|
| Citation Information for Mutations:
|
COSS1240187
|
| Verification Reference Profile:
|
DNA Profile (STR, source: ATCC):
Amelogenin: X
CSF1PO: 12
D13S317: 12
D16S539: 11,12
D5S818: 12
D7S820: 11
THO1: 7,9
TPOX: 8
vWA: 18
|
| Growth Properties:
|
not specified
|
| Recommended Culture Conditions:
|
From MGH/CMT as specified by cell provider: HITES medium supplemented with 5% fetal bovine serum. HITES medium with 5% fetal bovine serum is formulated at the ATCC as follows:
Dulbecco's medium : Ham's F12, 50:50 mix (ATCC 30-2006)
Insulin 0.005 mg/ml
Transferrin 0.01 mg/ml
Sodium selenite 30 nM
Hydrocortisone 10 nM
beta-estradiol 10 nM
HEPES 10 mM
L-glutamine 2 mM (in addition to that in the base medium)
fetal bovine serum 5%
|
| Relevant Citations:
|
|
| Usage Note:
|
|
| Comments:
|
|
| Date Publicly Available:
|
2012-04-25
|
| Most Recent Update:
|
2016-07-12
|